Pieris Pharmaceuticals
PIRS
#9913
Rank
S$23.52 M
Marketcap
$17.82
Share price
-15.58%
Change (1 day)
9.80%
Change (1 year)

Earnings for Pieris Pharmaceuticals (PIRS)

Earnings in 2024 (TTM): -S$29.86 Million

According to Pieris Pharmaceuticals's latest financial reports the company's current earnings are S$19.57 Million. In 2022 the company made an earning of -S$43.61 Million, an increase over its 2021 earnings that were of -S$59.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Pieris Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$29.86 Million
2022 -S$43.61 Million-27.24%
2021 -S$59.94 Million23.4%
2020 -S$48.57 Million45.53%
2019 -S$33.38 Million-5.89%
2018 -S$35.47 Million63.59%
2017 -S$21.68 Million-26.92%
2016 -S$29.67 Million63.39%
2015 -S$18.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.11 Billion 258.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$7.19 Million-75.21%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.90 B-3,219.21%๐Ÿ‡บ๐Ÿ‡ธ USA